MedPath

ANTICOAGULANT SODIUM CITRATE SOLUTION USP

ANTICOAGULANT SODIUM CITRATE SOLUTION USP

Discontinued
DIN Number

02344416

Drug Class

Human

Market Date

Nov 1, 2011

Company
HC

FENWAL INC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02344416
AIG Number0100377004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of Administration0-Unassigned
AHFS Classification20:12.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

SODIUM CITRATEActive
Strength: 4 G / 100 ML
Monograph: SODIUM CITRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.